Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Scholar Rock Holding Corporation, 3 years.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 11, 2025 | CAMP4 Therapeutics Corporation | Open-market purchase | +1,221,721 | $1.53 | $1,869,233 |
| Sep 11, 2025 | CAMP4 Therapeutics Corporation | Open-market purchase | +85,468 | $1.53 | $130,766 |
| Oct 15, 2024 | CAMP4 Therapeutics Corporation | Derivative conversion | +1,250,061 | — | — |
| Oct 15, 2024 | CAMP4 Therapeutics Corporation | Derivative conversion | +87,448 | — | — |
| Oct 15, 2024 | CAMP4 Therapeutics Corporation | Derivative conversion | +353,718 | — | — |
| Oct 15, 2024 | CAMP4 Therapeutics Corporation | Derivative conversion | +24,745 | — | — |
| Oct 15, 2024 | CAMP4 Therapeutics Corporation | Open-market purchase | +909,090 | $11.00 | $9,999,990 |
| May 9, 2024 | Scholar Rock Holding Corporation | Other | −472,394 | — | — |
| May 9, 2024 | Scholar Rock Holding Corporation | Other | +98,257 | — | — |
| May 9, 2024 | Scholar Rock Holding Corporation | Other | −98,257 | — | — |
| May 9, 2024 | Scholar Rock Holding Corporation | Other | +13,096 | — | — |
| May 9, 2024 | Scholar Rock Holding Corporation | Other | −27,606 | — | — |
| May 9, 2024 | Scholar Rock Holding Corporation | Other | +322 | — | — |
| May 9, 2024 | Scholar Rock Holding Corporation | Other | +276 | — | — |
| May 9, 2024 | Scholar Rock Holding Corporation | Other | −276 | — | — |
Questions about Amir Nashat
What boards is Amir Nashat on?
Amir Nashat sits on the boards of CAMP4 Therapeutics Corporation and Scholar Rock Holding Corporation.
How long has Amir Nashat served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.